Besides, our data support that fatty liver is perhaps an influencing factor for the association of serum SHBG level with MS in that when the parameter of NAFLD was added into our linear regression model, the association turned to be no longer statistically significant. This evidence concerns the gene SHBG and Hepatic steatosis.